Amber D Van Laar (Amber Van Laar)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Parkinson Disease

Transcription Factor

Top Venues

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Chadwick W Christine, R Mark Richardson, Amber D Van Laar, Elisabeth M Fine, Omar S Khwaja, Grace S Liang, Krystof Bankiewicz, Paul S Larson
Author Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial. Neurology 99 (6) (2022)
Chadwick W Christine, Robert Mark Richardson, Amber D Van Laar, Marin E Thompson, Elisabeth M Fine, Omar S Khwaja, Chunming Li, Grace S Liang, Andreas Meier, Eiry W Roberts, Madeline L Pfau, Josh R Rodman, Krystof S Bankiewicz, Paul S Larson
Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial. Neurology (2021)
Roberto Di Maio, Eric K Hoffman, Emily M Rocha, Matthew T Keeney, Laurie H Sanders, Briana R de Miranda, Alevtina Zharikov, Amber D Van Laar, Antonia F Stepan, Thomas A Lanz, Julia K Kofler, Edward A Burton, Dario R Alessi, Teresa G Hastings, J Timothy Greenamyre
LRRK2 activation in idiopathic Parkinson's disease. Science translational medicine 10 (451) (2019)